Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
From the Editor

Trying to get ahead of Alzheimer disease

Brian F. Mandell, MD, PhD
Cleveland Clinic Journal of Medicine September 2020, 87 (9) 517-518; DOI: https://doi.org/10.3949/ccjm.87b.09020
Brian F. Mandell
Roles: Editor in Chief
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Embedded Image

Current data from the Alzheimer’s Association indicate that 1 in 10 people age 65 and older has Alzheimer dementia; almost two-thirds are women. Since the disease process begins decades before the recognized features of the illness appear, the numbers are even more striking.

While I often struggle to characterize features of specific early dementias and distinguish them from mild cognitive impairment or from sleep disruption and the effects of stressors of an underlying medical illness, my geriatrics and neurology colleagues who diagnose and manage Alzheimer disease patients still rely greatly on the clinical history provided by patients and their companions. Loss of ability to accurately recall recent specific events or places seems to be more specific than word-finding challenges. Executive functions and multitasking may deteriorate relatively early in some, without visual hallucinations and parkinsonian features that characterize some patients with Lewy body disease. But the early clinical features of patients with different dementias often overlap. Sorting out patients destined to have Alzheimer disease from those with mild cognitive impairment, vascular dementia, and other disorders remains a challenge.

Routine magnetic resonance imaging, even with focal volume measurement, does not seem to reliably detect early Alzheimer disease. Functional fluorodeoxyglucose positron emission tomography (FDG-PET) is expensive and also not ideally specific in distinguishing Alzheimer patients from others with mild cognitive impairment. Specialized PET using probes to identify the amyloid beta plaques is not uniformly available and also is not perfectly specific when sorting out patients with mild cognitive impairment, but this technology is rapidly advancing.

Moreover, at present, despite the growing understanding of the pathophysiology of Alzheimer disease, we have no specific proven treatment for it. Hence, one can put forth the question of whether early diagnosis actually matters. The counter argument is that it may matter a great deal to the patient and family as they make personal and family plans and decisions. And there are relevant clinical issues as well. Perhaps the reason we have no proven effective therapies, despite development of sophisticated targeting agents based on the known pathophysiology of Alzheimer disease, is that we are limited in our ability to recognize early disease and its subtypes. The lack of readily available, affordable, practical, and accurate biomarkers hampers not only our ability to provide guidance to (potential) Alzheimer patients and their families, but also our ability to easily and accurately recruit the most appropriate patients for clinical trials.

There are useful diagnostic biomarkers in the cerebrospinal fluid (eg, decreased amyloid beta 1–42 and increased specific phosphorylated tau proteins), but obtaining these can be cumbersome, and while they can generally distinguish Alzheimer patients from otherwise healthy elder adults, there has still been some concern about their ability to discriminate this disease from other dementias. The logistics of obtaining a lumbar puncture and concern regarding the specificity of these tests combine to make cerebrospinal fluid biomarkers less than ideal in general practice.

In this issue of the Journal (page 537), Bekris and Leverenz summarize recent advances in the development of blood-based biomarkers for Alzheimer disease. While there has been some hype over potential “new tests” for this disease, the current status and associated caveats are outlined in their commentary.

A question for another day remains: If a very sensitive test became available to diagnose preclinical Alzheimer disease, would you request it for yourself?

  • Copyright © 2020 The Cleveland Clinic Foundation. All Rights Reserved.
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 87 (9)
Cleveland Clinic Journal of Medicine
Vol. 87, Issue 9
1 Sep 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Trying to get ahead of Alzheimer disease
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Trying to get ahead of Alzheimer disease
Brian F. Mandell
Cleveland Clinic Journal of Medicine Sep 2020, 87 (9) 517-518; DOI: 10.3949/ccjm.87b.09020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Trying to get ahead of Alzheimer disease
Brian F. Mandell
Cleveland Clinic Journal of Medicine Sep 2020, 87 (9) 517-518; DOI: 10.3949/ccjm.87b.09020
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • Emerging blood-based biomarkers for Alzheimer disease
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • The gift of lasting immunity
  • Psychedelics in the medical toolbox?
  • All sulfa drugs are not created equal
Show more From the Editor

Similar Articles

Subjects

  • Genetics
  • Geriatrics
  • Mental Health
  • Neurology
  • Preventive Care
  • Women's Health

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire